This modification transforms carnitine into an energy-transporting molecule, allowing fatty acids to be metabolized within mitochondria
It also helps lower fasting and postprandial blood glucose levels, leading to improved glycemic control
Approximately 15-20% of users experience significant changes in bowel habits
Whereas, some longitudinal studies have noticed a significant decrease in the IMT following a GLP-1-based therapy 14,36 , the present meta-analysis reveals a non-significant decrease in IMT, but this may be because of the less availability of data and paradigmatic and treatment spell deviations, thus necessitates the conduct of more trials with better designs
Narukawa, M., Kamiyoshihara, A., Izu, H., Fujii, T., Matsubara, K., & Misaka, T